Dongfang Biological: The company and its subsidiaries have obtained multiple medical device registration certificates.

Oriental Bio announced that the company and its wholly-owned subsidiaries Shanghai Wanzijian Biology, wholly-owned subsidiary UK Ecobio, and holding subsidiary Leihe Biology have obtained multiple domestic and foreign medical device registration certificates, including inflammation marker test kits, COVID-19/FluA&B antigen detection kits, RapidFluA&B/RSV/AdenoAntigen Tests, etc. The acquisition of these registration certificates will further enrich the company's product range, which is beneficial for market expansion. However, actual sales performance will depend on product competitiveness and market sales capabilities, and the impact on the company's future operating performance cannot be predicted at present.